Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Richard Ambinder"'
Autor:
Catherine Diefenbach, Opeyemi Jegede, Richard Ambinder, Jonathon Cohen, Michael Robertson, Kevin David, Ranjana Advani, Timothy Fenske, Stefan Barta, Neil Palmisiano, Jakub Svoboda, David Morgan, Reem Karmali, Brad Kahl, Stephen M. Ansell
Publikováno v:
HemaSphere, Vol 6, Pp 46-47 (2022)
Externí odkaz:
https://doaj.org/article/747d3fe7b84b48909dc89cf4beb50fee
Autor:
Hao-Wei Wang, Jomy George, Kathryn Lurain, Ramya Ramaswami, Ralph Mangusan, Anaida Widell, Irene Ekwede, Richard Ambinder, Priscila H Goncalves, Robert Yarchoan
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 2 (2021)
Background Non-Hodgkin’s lymphoma (NHL) is currently the most common malignancy among people living with HIV (PLWH) in the USA. NHL in PLWH is more frequently associated with oncogenic viruses than NHL in immunocompetent individuals and is generall
Externí odkaz:
https://doaj.org/article/6d8f5c5ee6c048a79a74b0603e352575
Autor:
Samantha L. Vogt, Moosa Patel, Tanvier Omar, Sugeshnee Pather, Neil Martinson, Richard Ambinder
Publikováno v:
Journal of Global Oncology, Vol 4, Pp 1-6 (2017)
Externí odkaz:
https://doaj.org/article/121baa6f5255446ab63ae2c37c7c9e56
Autor:
Lee Ratner, William Harrington, Xuan Feng, Christian Grant, Steve Jacobson, Ariela Noy, Joseph Sparano, Jeannette Lee, Richard Ambinder, Nancy Campbell, Michael Lairmore, AIDS Malignancy Consortium
Publikováno v:
PLoS ONE, Vol 4, Iss 2, p e4420 (2009)
BackgroundHuman T-cell leukemia virus-associated adult T-cell leukemia-lymphoma (ATLL) has a very poor prognosis, despite trials of a variety of different treatment regimens. Virus expression has been reported to be limited or absent when ATLL is dia
Externí odkaz:
https://doaj.org/article/c7fe39eca7bd417bbae03db9ff98ee58
Autor:
Cole Sterling, Michael Hughes, Hua-Ling Tsai, Kathryn Yarkony, Ephraim Fuchs, Lode Swinnen, Suman Paul, Javier Bolaños-Meade, Leo Luznik, Philip Imus, Syed Ali, Tania Jain, Alexander Ambinder, Amy DeZern, Carol Huff, Christian Gocke, Ravi Varadhan, Nina Wagner-Johnston, Richard John Jones, Richard Ambinder
While allogeneic blood or marrow transplantation (alloBMT) is an effective therapy for peripheral T-cell lymphoma (PTCL), the optimal approach in this patient population remains to be determined. Here we review outcomes in 65 consecutive patients wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8fd767f277d4c2f50bafdd72e9a08d66
https://doi.org/10.21203/rs.3.rs-2007516/v1
https://doi.org/10.21203/rs.3.rs-2007516/v1
Autor:
Tania Jain, Hua-Ling Tsai, Amy E. DeZern, Lukasz P. Gondek, Hany Elmariah, Javier Bolaños-Meade, Leonido Luznik, Ephraim Fuchs, Richard Ambinder, Douglas E. Gladstone, Philip Imus, Jonathan Webster, Gabrielle Prince, Gabriel Ghiaur, B. Douglas Smith, Syed Abbas Ali, Alexander Ambinder, William B. Dalton, Christian B. Gocke, Carol Ann Huff, Ivana Gojo, Lode Swinnen, Nina Wagner-Johnston, Ivan Borrello, Ravi Varadhan, Mark Levis, Richard J. Jones
Publikováno v:
Transplant Cell Ther
We describe outcomes after post-transplantation cyclophosphamide and nonmyeloablative conditioning-based allogeneic blood or marrow transplantation for myelofibrosis using matched or mismatched related or unrelated donors. The conditioning regimen co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64f682f44b2cddb9b941d9a7eb4487e3
https://europepmc.org/articles/PMC9081210/
https://europepmc.org/articles/PMC9081210/
Autor:
Jennifer, Kanakry, Richard, Ambinder
Publikováno v:
Current topics in microbiology and immunology. 391
Epstein-Barr virus (EBV) DNA in blood can be quantified in peripheral blood mononuclear cells, in circulating cell-free (CCF) DNA specimens, or in whole blood. CCF viral DNA may be actively released or extruded from viable cells, packaged in virions
Autor:
Ariela, Noy, Jeannette Y, Lee, Ethel, Cesarman, Richard, Ambinder, Robert, Baiocchi, Erin, Reid, Lee, Ratner, Nina, Wagner-Johnston, Lawrence, Kaplan, Michael, Craig
Publikováno v:
Blood. 126(2)
The toxicity of dose-intensive regimens used for Burkitt lymphoma prompted modification of cyclophosphamide, vincristine, doxorubicin, high-dose methotrexate/ifosfamide, etoposide, and high-dose cytarabine (CODOX-M/IVAC) for HIV-positive patients. We
Autor:
Christine Durand, Richard Ambinder
Publikováno v:
Encyclopedia of AIDS ISBN: 9781461496106
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc1db56493561845b892e1d6ffc508bb
https://doi.org/10.1007/978-1-4614-9610-6_24-1
https://doi.org/10.1007/978-1-4614-9610-6_24-1